Introduction

About the conference..

TREAT-NMD is an international network currently funded by the EU that aims to advance diagnosis, care and therapy development for the benefit of patients and families. It links scientists and healthcare professionals, the pharmaceutical industry, regulators and patient groups all over the world.

This international conference provides a unique focus on the challenges facing therapy development for inherited neuromuscular diseases.

PROGENA FOUNDATION, local host and co-organiser of this conference, is a Swiss patient organisation raising funds for the research against rare genetic diseases and providing support for families.

The conference sessions will look at the range of issues involved in therapy development in inherited neuromuscular diseases as well as discussing the latest research developments in this area.

Download a PDF of the conference programme.

The conference flyer is available to download here.

Download TREAT-NMD 2011 conference flyer

 

Official Hotel Partner

Starling Hotel Geneva

With the support of

Canton of Geneva

TREAT-NMD acknowledges the following sponsors
Gold sponsors
Myosuisse
genzyme website
Silver sponsors

Prosensa website

Pfizer website
PTC website
Santhera website
Acceleron website

Shire website

 

Deutsche Muskelstiftung website


MDA website
AVIBioPharma Website
Ultragenyx website
General sponsors

Trophos website

CHUV website

Foundation to Eradicate Duchenne website

Cure Duchenne website

MDC website

ISIS website

 

 
22 Feb 2012